Crossmark

miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1

Published Online: 2016-11-10

Published Print: 2016-12

Authors

Wang, Yuan

Lieberman, Rachel

Pan, Jing

Zhang, Qi

Du, Meijun

Zhang, Peng

Nevalainen, Marja

Kohli, Manish

Shenoy, Niraj K.

Meng, Hui

You, Ming

Wang, Liang
Funding

Funding for this research was provided by:

National Institutes of Health (R01CA157881)

Advancing a Healthier Wisconsin Fund (5520227)
License Information

Text and Data Mining valid from 2016-11-10

Version of Record valid from 2016-11-10
More Information

Article History

Received: 6 June 2016

Accepted: 2 November 2016

First Online: 10 November 2016

Document is current